Tse‐Ching Chen

1.4k total citations
26 papers, 1.0k citations indexed

About

Tse‐Ching Chen is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Tse‐Ching Chen has authored 26 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 11 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Tse‐Ching Chen's work include Cholangiocarcinoma and Gallbladder Cancer Studies (17 papers), Gallbladder and Bile Duct Disorders (9 papers) and Pediatric Hepatobiliary Diseases and Treatments (8 papers). Tse‐Ching Chen is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (17 papers), Gallbladder and Bile Duct Disorders (9 papers) and Pediatric Hepatobiliary Diseases and Treatments (8 papers). Tse‐Ching Chen collaborates with scholars based in Taiwan, Japan and United States. Tse‐Ching Chen's co-authors include Yi-Yin Jan, Ta‐Sen Yeh, Miin‐Fu Chen, Yoh Zen, Yuji Nimura, Yasuni Nakanuma, Yasuni Nakanuma, Motoko Sasaki, Shiu-Feng Huang and Ling‐Ling Hsieh and has published in prestigious journals such as Hepatology, Clinical Infectious Diseases and Annals of Surgery.

In The Last Decade

Tse‐Ching Chen

26 papers receiving 985 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tse‐Ching Chen Taiwan 15 860 490 370 123 122 26 1.0k
A. Wein Germany 16 309 0.4× 485 1.0× 260 0.7× 154 1.3× 91 0.7× 43 777
Wigdan Al-Sukhni Canada 10 268 0.3× 437 0.9× 152 0.4× 132 1.1× 68 0.6× 13 631
Samy Louafi France 9 221 0.3× 374 0.8× 126 0.3× 134 1.1× 61 0.5× 16 801
Fujio Hanyu Japan 14 663 0.8× 428 0.9× 437 1.2× 164 1.3× 35 0.3× 86 894
Thomas DeLeon United States 10 237 0.3× 244 0.5× 116 0.3× 166 1.3× 123 1.0× 19 526
Kenneth Seier United States 9 251 0.3× 430 0.9× 189 0.5× 59 0.5× 139 1.1× 21 629
Yoshihito Kotera Japan 15 554 0.6× 375 0.8× 211 0.6× 441 3.6× 96 0.8× 51 921
T. T. Wu United States 11 235 0.3× 138 0.3× 292 0.8× 61 0.5× 102 0.8× 13 596
Robert Hüneburg Germany 13 205 0.2× 185 0.4× 141 0.4× 124 1.0× 76 0.6× 31 599
Ki Jung Yun South Korea 13 233 0.3× 178 0.4× 177 0.5× 42 0.3× 237 1.9× 43 687

Countries citing papers authored by Tse‐Ching Chen

Since Specialization
Citations

This map shows the geographic impact of Tse‐Ching Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tse‐Ching Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tse‐Ching Chen more than expected).

Fields of papers citing papers by Tse‐Ching Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tse‐Ching Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tse‐Ching Chen. The network helps show where Tse‐Ching Chen may publish in the future.

Co-authorship network of co-authors of Tse‐Ching Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Tse‐Ching Chen. A scholar is included among the top collaborators of Tse‐Ching Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tse‐Ching Chen. Tse‐Ching Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Chien‐Ming, Shang‐Yu Wang, Ren‐Chin Wu, et al.. (2023). Intraductal papillary neoplasm of the bile duct presenting with hepatogastric fistula: a case report and literature review. Frontiers in Oncology. 13. 1193918–1193918. 1 indexed citations
2.
Tsai, Chun‐Yi, Shang‐Yu Wang, Kun‐Ming Chan, et al.. (2022). Hepatectomy or/with Metastatectomy for Recurrent Intrahepatic Cholangiocarcinoma: Of Promise for Selected Patients. Journal of Personalized Medicine. 12(4). 540–540. 2 indexed citations
3.
Chen, Huan‐Wu, Chun‐Yi Tsai, Tse‐Ching Chen, et al.. (2021). The optimal timing of interval laparoscopic cholecystectomy following percutaneous cholecystostomy based on pathological findings and the incidence of biliary events. Journal of Hepato-Biliary-Pancreatic Sciences. 28(9). 751–759. 7 indexed citations
4.
Chen, Tse‐Ching, Yi-Yin Jan, & Ta‐Sen Yeh. (2012). K-ras Mutation is Strongly Associated with Perineural Invasion and Represents an Independent Prognostic Factor of Intrahepatic Cholangiocarcinoma after Hepatectomy. Annals of Surgical Oncology. 19(S3). 675–681. 40 indexed citations
5.
Yeh, Chun‐Nan, Ta‐Sen Yeh, Tse‐Ching Chen, Yi-Yin Jan, & Miin‐Fu Chen. (2012). Gross pathological classification of peripheral cholangiocarcinoma determines the efficacy of hepatectomy. Journal of Gastroenterology. 48(5). 647–659. 10 indexed citations
6.
Liu, Keng-Hao, et al.. (2009). Enterovesical fistula caused by a bladder squamous cell carcinoma. World Journal of Gastroenterology. 15(33). 4215–4215. 12 indexed citations
7.
Lin, Kun‐Ju, Chien‐Hung Liao, Ing‐Tsung Hsiao, et al.. (2009). Improved hepatocyte function of future liver remnant of cirrhotic rats after portal vein ligation: A bonus other than volume shifting. Surgery. 145(2). 202–211. 16 indexed citations
8.
Wakai, Kenji, Koji Oda, Junichi Kamiya, et al.. (2008). Lifestyle risk factors for intrahepatic stone: Findings from a case–control study in an endemic area, Taiwan. Journal of Gastroenterology and Hepatology. 23(7pt1). 1075–1081. 6 indexed citations
9.
Yeh, Ta‐Sen, Jeng‐Hwei Tseng, Cheng‐Tang Chiu, et al.. (2006). Cholangiographic Spectrum of Intraductal Papillary Mucinous Neoplasm of the Bile Ducts. Annals of Surgery. 244(2). 248–253. 76 indexed citations
10.
Zen, Yoh, Kenichi Harada, Motoko Sasaki, et al.. (2005). Intrahepatic cholangiocarcinoma escapes from growth inhibitory effect of transforming growth factor-β1 by overexpression of cyclin D1. Laboratory Investigation. 85(4). 572–581. 39 indexed citations
11.
12.
Yeh, Ta‐Sen, Jeng‐Hwei Tseng, Tse‐Ching Chen, et al.. (2005). Characterization of Intrahepatic Cholangiocarcinoma of the Intraductal Growth-Type and Its Precursor Lesions *. Hepatology. 42(3). 657–664. 69 indexed citations
13.
Shimonishi, Tomonori, Yoh Zen, Tse‐Ching Chen, et al.. (2002). Increasing expression of gastrointestinal phenotypes and p53 along with histologic progression of intraductal papillary neoplasia of the liver. Human Pathology. 33(5). 503–511. 50 indexed citations
14.
Harada, Kenichi, Yoh Zen, Tse‐Ching Chen, et al.. (2001). Human Reg I Gene Is Up–Regulated in Intrahepatic Cholangiocarcinoma and Its Precursor Lesions. Hepatology. 33(5). 1036–1042. 59 indexed citations
15.
Chen, Tse‐Ching, Tze-Bin Chou, Kwai‐Fong Ng, Ling‐Ling Hsieh, & Yah-Huei Chou. (2000). Hepatocellular carcinoma associated with focal nodular hyperplasia. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 438(4). 408–411. 26 indexed citations
16.
Tang, Jui‐Hsiang, Chau‐Ting Yeh, Tse‐Ching Chen, et al.. (1998). Emergence of an S Gene Mutant during Thymosin α1Therapy in a Patient with Chronic Hepatitis B. The Journal of Infectious Diseases. 178(3). 866–869. 14 indexed citations
17.
18.
Chen, Miin‐Fu, Yi-Yin Jan, & Tse‐Ching Chen. (1998). Clinical Studies of Mucin-Producing Cholangiocellular Carcinoma. Annals of Surgery. 227(1). 63–69. 66 indexed citations
19.
Yeh, Ta‐Sen, et al.. (1998). Hepatocellular Carcinoma Presenting as Pyogenic Liver Abscess: Characteristics, Diagnosis, and Management. Clinical Infectious Diseases. 26(5). 1224–1226. 30 indexed citations
20.
Yeh, Chih‐Ching, et al.. (1997). Quantitative assessment of serum hepatitis B virus DNA: comparison between two different methods. International Hepatology Communications. 7(3). 159–167. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Wein Breakdown of academic impact, for papers by Wigdan Al-Sukhni Breakdown of academic impact, for papers by Samy Louafi Breakdown of academic impact, for papers by Fujio Hanyu Breakdown of academic impact, for papers by Thomas DeLeon Breakdown of academic impact, for papers by Kenneth Seier Breakdown of academic impact, for papers by Yoshihito Kotera Breakdown of academic impact, for papers by T. T. Wu Breakdown of academic impact, for papers by Robert Hüneburg Breakdown of academic impact, for papers by Ki Jung Yun
Rankless by CCL
2026